Loading
IMATERO

About IMATERO

Imatero contains Imatinib Mesylate as composition. Imatinib is the first molecule in the world which gives hope for a potential cure in cancer patients (only if the disease is in early stage). Imatero brand is used as a backbone therapy for the treatment of Chronic Myeloid Leukaemia (CML) patients. Imatero belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Imatero 100Mg Tablet and Imatero 400Mg Tablet.